C-

Qiuying Qin1,2, Xiaoxuan Kou1,2, Yuanyuan Zheng1,2

  • 1State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, People's Republic of China.

PubMed
概括

早期的C-反应蛋白 (CRP) 动力学可以预测肝细胞癌 (HCC) 患者接受免疫检查点阻塞 (ICB) 的治疗成功. CRP爆发反应是免疫疗法的有效性和改善HCC患者生存结果的强有力的指标.